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Abstract
Nicotinic acetylcholine receptors have been shown to participate in neuroprotection in the aging 
brain. Lynx protein modulators dampen the activity of the cholinergic system through direct 
interaction with nicotinic receptors. Although lynx1 null mutant mice exhibit augmented learning 
and plasticity, they also exhibit macroscopic vacuolation in the dorsal striatum as they age, 
detectable at the optical microscope level. Despite the relevance of the lynx1 gene to brain 
function, little is known about the cellular ultrastructure of these age-related changes. In this study, 
we assessed degeneration in the dorsal striatum in 1-, 3-, 7-, and 13-month-old mice, using optical 
and transmission electron microscopy. We observed a loss of nerve fibers, a breakdown in nerve 
fiber bundles, and loss of neuronal nuclei in the 13-month-old lynx1 null striatum. At higher 
magnification, these nerve fibers displayed intracellular vacuoles and disordered myelin sheaths. 
Few or none of these morphological alterations were present in younger lynx1 null mutant mice, 
or in heterozygous lynx1 null mutant mice at any age. These data indicate that neuronal health can 
be maintained by titrating lynx1 dosage, and that the lynx1 gene may participate in a trade-off 
between neuroprotection and augmented learning.
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Introduction
Throughout life, the cholinergic system provides important control over a number of 
neurotransmitter systems that participate in a variety of brain functions (Miwa et al., 2011; 
Picciotto, 2003). Cholinergic activation can have beneficial effects, promoting plasticity, 
learning (Levin et al., 2005) (Picciotto et al., 1995), and neuroprotective mechanisms 
(Bordia et al., 2008; Quik et al., 2007; Ryan et al., 2001; Stevens et al., 2003). 
Overactivation of the cholinergic system, however, has been linked to cell death (Orb et al., 
2004; Orr-Urtreger et al., 2000), whereas, conversely, hypoactivity of the cholinergic system 
has been linked with neurodegenerative conditions such as Alzheimer's disease 
(Albuquerque et al., 2009; Decker and McGaugh, 1991; Terry and Buccafusco, 2003). 
Epidemiological evidence supports an inverse correlation between smoking and 
neurodegenerative disorders such as Parkinson’s disease, implying a further connection 
between nicotinic acetylcholine receptors and neurodegeneration; smoking seems to provide 
some neuroprotection against Parkinson’s disease (Huang et al., 2007; Picciotto and Zoli, 
2008). Titrating the amount of cholinergic activation is therefore critical for normal brain 
function and for neuronal health.
During normal aging, cholinergic neurons and specific nicotinic acetylcholine receptor 
subtypes are eliminated selectively or reduced (Albuquerque et al., 2009; Terry and 
Buccafusco, 2003). This loss is thought to underlie cognitive decline, which is not a 
pathology, but part of the aging process (Picciotto, 2003). In certain pathologies, such as 
Alzheimer's disease and other dementias, there is a selective loss of various nicotinic 
acetylcholine receptor subtypes (Albuquerque et al., 2009), cholinergic neurons (Decker and 
McGaugh, 1991; Schliebs and Arendt, 2011), or axons of cholinergic neurons (Geula et al., 
2008), which all play a role in the clinical manifestation of these diseases. In 
neurodegenerative disorders, therapies using acetylcholinesterase inhibitors can augment the 
contribution of the cholinergic system in improving cognition (Terry and Buccafusco, 2003). 
These therapies inhibit the enzyme that breaks down the neurotransmitter acetylcholine, 
acetylcholinesterase, and thus raise overall acetylcholine levels in the brain. Balancing this 
activity is critical because moderate activation of the cholinergic system can enhance 
cognitive functions, whereas overactivation can be detrimental (Picciotto, 2003). Thus, this 
inverted U-shaped relationship between activity and function requires tight regulation 
(Miwa et al., 2011).
Nicotinic acetylcholine receptors are ligand-gated ion channels of the cholinergic system 
that have been implicated in neuronal degeneration (Terry and Buccafusco, 2003) and 
survival (Dajas-Bailador et al., 2000; Kaneko et al., 1997; Stevens et al., 2003). Activation 
of these receptors leads to a rise in intracellular Ca2+ levels (Berger et al., 1998), partially 
because some subtypes allow Ca2+ to flux directly into the cell (Yamauchi et al., 2011). 
Animal studies indicate a neuroprotective effect of nicotine on mouse models of 
neurodegeneration (Ryan et al., 2001), suggesting a role of nicotinic acetylcholine receptors 
in neuroprotective mechanisms (Picciotto and Zoli, 2008; Stevens et al., 2003). It is well 
known that regulation of the activity of the cholinergic system is important in protecting 
neurons as they age (Albuquerque et al., 2009; Terry and Buccafusco, 2003).
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The toxin-like modulators of the lynx family provide promising avenues for manipulation of 
cholinergic system activation levels. Lynx molecules are endogenous proteins that bind 
tightly to nicotinic acetylcholine receptors and modulate their function (Ibanez-Tallon et al., 
2002; Miwa et al., 1999; Tekinay et al., 2009). Lynx1KO mice exhibit elevated nicotinic 
receptor responses, greater plasticity (Morishita et al., 2010), and increased learning and 
memory (Miwa et al., 2006). Our previous study also showed that neurons from lynx1KO 
mice exhibit elevated intracellular Ca2+ levels and enhanced nicotine-evoked rises in Ca2+ 
(Miwa et al., 2006). Lynx1KO neurons, however, are also more susceptible to glutamate-
mediated neurotoxicity, and nicotine neuroprotection in vitro is abolished. Optical 
microscopic examination revealed that homozygous lynx1KO mice at the age of 12 months 
and older display vacuoles in the striatum and brainstem. This vacuolation can be 
ameliorated by crossing lynx1KO mice to α7 or β2 null mutant mice, indicating that 
nicotinic acetylcholine receptor subunits are downstream effectors of lynx1 signaling.
Despite the link between levels of nicotinic receptor activity and neuron vulnerability, the 
role of lynx1 in this vacuolating degenerative process is unknown. To date, no detailed 
examination of the pathological features in the lynx1 mouse model has been undertaken. We 
therefore investigated the degeneration in the dorsal striatum as a function of age using 
optical and transmission electron microscope (TEM) ultrastructural analyses. Using TEM, 
we found two types of degeneration occurring in the dorsal striatum. One is an external 
degeneration, which occurs at the level of fascicle disorganization, such as a loss of nerve 
fibers and a loss of neuronal cell bodies. The other is an internal degeneration, which 
appears to be a degenerative change in axoplasm of axon fibers. The fascicles were compact 
with distinct boundaries in wildtype brains, but were indistinct with fuzzy margins in 
lynx1KO brains. When we examined axon and nerve fibers in cross section within the 
fascicles using TEM, we discovered unusual morphological alterations such as disordered 
myelin sheaths, axoplasmic anomalies, and vacuoles.
We have reported that lynx mRNA levels can be regulated by environmental and other 
manipulations (Miwa et al., 2011). This opens up the possibility that the brain may be 
subjected to altered amounts of susceptibility to neuronal damage. To understand the role of 
lynx1 dosage in cholinergic activity, we compared the effect of partial removal of lynx1, 
exhibited in heterozygous mice, to complete removal of lynx1 as exists in homozygous 
knockout mice.
The lynx1KO animals were largely normal during development and into early adulthood. 
We found that lynx1KO animals over one year of age have clear ultrastructural differences 
in the striatum, but this is largely spared in the heterozygous mice. This age-related 
degenerative phenotype in lynx1KO mice implicates lynx1 in neuronal health during aging.
Materials and Methods
Animals
lynx1KO mice were maintained as a backcross on a C57BL/6 (Charles River) background 
for > 8 generations. Heterozygous lynx1KO mice were intercrossed to derive a mixture of 
wildtype, heterozygous and homozygous lynx1KO mice. Lynx1KO mice used in this study 
Kobayashi et al. Page 3
J Mol Neurosci. Author manuscript; available in PMC 2015 July 17.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
were all homozygous for lynx1KO. Animals were treated according to the guidelines 
detailed in the Guide for the Care and Use of Laboratory Animals, at the OLAR facility, 
California Institute of Technology, IACUC protocol number 1386-10G. All samples (1, 3, 7 
and 13 month old of wildtype and lynx1KO) were prepared and analyzed with the 
investigator blinded to genotype.
Electron Microscopic analyses
Adult mice were used to examine the ultrastructure of nerve fibers in the dorsal striatum. 
Animals were perfused transcardially with saline/heparin followed by 1.25% glutaraldehyde 
and 1.5% sucrose in 0.1 M phosphate buffer (PB). Brains were fixed and sectioned coronally 
at 60 µm thickness on a vibrating microtome with 5% sucrose in 0.1 M PB. Sections were 
then postfixed with 2.0% glutaraldehyde and 1.5% sucrose in 0.1 M cacodylate buffer 
(pH7.4). Osmolarity was maintained at ~400 mOs throughout the fixation process (Cragg, 
1980). Sections were then incubated in 2% osmium tetroxide with 0.8% K ferricyanide and 
5% sucrose in 0.1 M Na cacodylate buffer for one hour followed by 2% aqueous uranyl 
acetate prestaining for 30 minutes in darkness. Sections were dehydrated in an acetone series 
and then embedded in EMBed 812 (Electron Microscopy Sciences). The samples were then 
cut into 60 nm thin sections with a diamond knife (DiATOME) on a Leica Ultracut UCT 
ultramicrotome. The thin sections were collected on a TEM grid, then post-stained with a 
2% uranyl acetate and Reynold’s lead citrate. For TEM imaging we used a Tecnai T12 
operating at 120 kV., equipped with a Gatan Ultrascan 2k X 2k CCD camera. For analysis in 
the dorsal striatum we acquired many images to create montages of fascicles. Micrographs 
were quantified using Illustrator and ImageJ software. The number of fascicles was 
determined using Cell Counter and area measurements (# of fibers/µm2).
Quantitative PCR
Tissue was quickly dissected on a cooled dissecting surface and placed into RNAlater 
stabilization reagent (Qiagen). Tissue was homogenized using a Bullet Blender homogenizer 
(Next Advance) with RNAse free metal beads to disrupt tissue. Homogenized tissue was 
quickly centrifuged and RNA was purified from supernatant using RNeasy columns 
(Qiagen). RNA was analyzed on a Bioanalyzer and subjected to RT reactions using 500 ng 
RNA (Quanta BioSciences). qPCR was performed in triplicate using a lynx1 TaqMan assay 
with GAPDH and HPRT as reference genes (Life Technologies) at a cDNA concentration of 
1 ng per well. Experimental design and analysis was performed as per MIQE guidelines.
Western Blot
Protein extracts were prepared using a buffer solution of 2% SDS and 2% BME in PBS. 
Tissue was homogenized using Bullet Blender homogenizer. Extracts were centrifuged and 
supernatants run out on a 7% SDS-PAGE gel. Gels were blotted onto nitrocellulose 
membranes and blocked with 5% milk in TBS-T. Primary antibodies were applied at 1:500 
dilution, and secondary antibodies incubated at 1:1000. Quantitation was performed using 
Li-COR system to measure anti-lynx1 bands, normalized to the actin bands for each sample. 
Triplicate samples were analyzed for each mouse brain.
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Immunohistochemistry
We conducted immuno-labeling using the avidin biotin complex (Spencer-Segal et al., 
2011). 13 month old mice were perfused transcardially with saline/heparin followed by 4% 
paraformaldehyde / 0.1% glutaraldehyde in 0.1 M PB and post-fixed for 0.1 M PB and post-
fixed for 2 h and then stored in 25 % sucrose/0.1 M PB overnight. Brains were sectioned 
coronally at 30 µm thickness on a vibrating microtome with 5% sucrose in 0.1 M PB. 
Sections were treated with 1% sodium borohydride in 0.1 M PB for 2×20 minutes followed 
by avidin/biotin blocking agent for 15 minutes each, and by blocking buffer (2% normal 
goat serum, 1% bovine serum albumin, 0.1% CWFS in phosphate buffer saline PBS), and 
then incubated in mouse anti-Neuronal NeuN (Chemicon) for three days at 4°C. The control 
sections were treated with nonspecific IgG (Sigma-Aldrich). Sections were washed with 
incubation buffer (0.1% BSA-c in PBS) for 30 minutes. The sections were then incubated in 
biotinylated goat anti-mouse IgG (H+L) antibody (Kirkegaard & Perry Laboratories, Inc.) 
for two days at 4°C in darkness. After washing with incubation buffer for 3×5 minutes, 
sections were post-fixed with 2% glutaraldehyde in 0.1 M PB for 15 minutes. Sections were 
then labeled with peroxidase-conjugated streptavidin (DAKO). Labeling was visualized with 
stable diaminobenzidine (Invitrogen) and hydrogen peroxide. Labeled sections mounted on 
slides were examined by a Leica DM2500P microscope with 10x and 63x objectives.
Images were imported into Photoshop and divided into quadrants. Quadrant files were 
imported into ImageJ and the number of NeuN positive cells were quantified using the Cell 
Counter plug-in. Numbers for each quadrant were averaged and analyzed using ANOVA 
with post-hoc Tukey honest significant difference (HSD) test.
Results
We performed a TEM evaluation of lynx1KO mouse striatum, an area of substantial 
disruption at the light microscopic level. Within the striatum, nerve fibers (marked as N in 
figures 1 and 2) run in compact bundles, which we refer to as fascicles (drawn in dotted 
lines). In coronal cross sections, the majority of these fascicles have distinct boundaries 
demarcating them from the striatal neuropil, which is the rest of the striatal tissue external to 
these fascicles. Our past histological studies of 6, 9, 12, 15 and 18 month old mice showed 
that lynx1KO animals start to exhibit vacuolar degeneration in the tissues of the dorsal 
striatum at 12 months of age. We therefore employed TEM to investigate the degeneration 
of striatal tissues in more detail in animals aged 1, 3, 7 and 13 months.
Loss of lynx1 in aging alters the shape of nerve fiber bundles, and their borders are no 
longer defined
We generated cross section montages of the nerve fiber bundles in the dorsal striatum. In 1 
month old wildtype (figure 1A) and lynx1KO (figure 1B) mice, fiber bundles appeared 
largely similar. In 3 month old-mice, both the wildtype (figure 1C) and lynx1KO (figure 1D) 
mouse striata were unchanged from 1 month old striata; the packing density of bundles 
within lynx1KO mice resembled wildtype. In 7 month old-mice, fascicles appeared largely 
similar in the wildtype (figure 2A) and lynx1KO (figure 2B) and the density of nerve fibers 
(marked N in figures) within the fascicles continued to look largely similar between the two 
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genotypes, indicating that there were only subtle differences between wildtype and lynx1KO 
mice in dorsal striatum up to that point.
In 13 month old-mouse brains, however, there was a striking difference in the structures in 
the dorsal striatum (figure 2C, D). In the montages of lynx1KO mouse brains, there were no 
defined borders to the nerve fascicles (figure 2D). The borders of the fascicles were 
indistinct (marked “?” in figure 2D), discontinuous in places, and the nerve fibers within the 
fascicle were dispersed with gaps between them (figure 2D). In the wildtype mouse brains of 
the same age, the border of the fascicles continued to appear smooth and regular, and the 
overall geometries of these fascicles appeared contiguous and intact (figure 2C).
We quantified the nerve fiber density in striatal montages to compare young (1- and 3- 
month-old) vs. aged (13- month-old) brains (Fig. 2e). We found a significant effect by 
ANOVA [F(3,11)=6.11, p<0.01] when comparing the 13-month-old lynx1KO fiber density 
(M = 56.4%, SEM ± 9.3%) to that of 13 month old wild type (M =100.0%, SEM ± 5.8%), 
young wild type (M = 88.2%, SEM ± 11.0%), and young lynx1KO samples (M = 77.1%, 
SEM ± 4.2%). Data were normalized and presented as a percentage of the density in the 13-
month-old wild-type condition. Post-hoc comparisons using the Tukey HSD test indicated 
that the mean score for the 13-month-old homozygous KO condition was significantly 
different from the 13-month-old wild-type condition (p<0.01). Because we did not detect 
significant differences in nerve fiber density between wild type and lynx1KO brains in 
young animals, we conclude that the reduction in nerve fiber density in the 13-month-old 
lynx1KO is a progressive effect that occurs during aging.
Aging lynx1KO mice exhibit internal disruptions within axon fiber bundles
At higher TEM magnification, we examined the nerve fibers within the fascicles. The nerve 
fibers were markedly different between the 13 month old lynx1KO (figure 3C and D) and 
age-matched wildtype sections (figure 3A and B). Whereas the wildtype axons had ordered 
myelin sheaths, the lynx1KO axons were highly disordered (marked SD in figure 3D). In 
addition, the extent of myelination appears to be reduced in the lynx1KO samples as 
compared to the wildtype samples. In the lynx1KO mice (figure 3C and D) some of the 
nerve fibers have vacuoles (marked NV in figure 3), which were not observed in the 
wildtype sections.
Aging lynx1KO mice display degeneration in striatal neurons
We wanted to ascertain whether the morphological alterations of aging lynx1KO brains 
were confined to nerve fibers traversing the striatum or if other sub-regions, such as the 
regions between the fascicles – the striatal neuropil - were also affected. We therefore 
performed TEM on the striatal neuropil, which contain relatively more cell bodies and fewer 
nerve fibers of passage than in the fascicular region. These regions contain dendritic 
(marked as DR in figure 4) and somatic (figure 5) structures. In the 13 month old sections of 
wildtype (figure 4A and B), it was evident that nerve fibers in the region were surrounded by 
a dense network of tissue containing many dendrites. The lynx1KO, however, exhibits a 
striking disruption in the striatal neuropil (figure 4C and D), with areas between dendrites 
and other structures having a very low density (marked E in figure 4C and D). Furthermore, 
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we saw signs of degeneration in the nucleus in the lynx1KO samples, with cases of both 
condensed nuclei and cleared nuclei (figure 5B). In the wildtype samples, however, the 
nuclei appeared to be intact with no condensation (figure 5A).
Age-related degenerative features are spared in heterozygous lynx1KO mice
Because of the severity of the phenotype in aged mice without lynx1, we wanted to 
determine if partial dosage of lynx1 would result in a less severe phenotype. We confirmed 
by qPCR analysis that heterozygous lynx1KO mice had a 50% reduction in lynx1 transcript 
levels in total brain extracts as compared to those of wildtype mice (figure 6C). We noted a 
corresponding reduction of lynx1 protein by Western blot analysis (figure 6A) from protein 
extracts of heterozygous brains compared to wildtype levels. Quantitative assessment 
indicates that lynx1 protein is expressed at about 50% of wildtype levels of protein (figure 
6B).
We generated cross section montages of the fascicles in the dorsal striatum. Interestingly, in 
the 13 month old heterozygous mice (figure 7A) there was little evidence of such structural 
alteration as (?) can be observed in homozygous lynx1KO aging mice (figure 2D). At higher 
TEM magnification we examined the nerve fibers (marked as N in figure 7B) within the 
fascicles in the heterozygous lynx1KO mice. The heterozygous mice fibers had ordered 
myelin sheaths, same as the wildtype mice. In the striatal neuropil, the regions between the 
fascicles contain relatively few nerve fibers of passage (figure 7C). This tissue contained 
many dendrites (marked as DR in figure 7C) and was densely filled, as seen in the wildtype 
case. In the heterozygous lynx1KO mice, the nuclei appeared to be intact with no 
condensation (marked as Nucleus in figure 7A). Nerve fiber density measurements of 
fascicle montages did not show a significant difference between aged wildtype and 
heterozygous animals, while aged homozygous lynx1KO animals showed a significant 
reduction in nerve fiber density. There was a significant effect of genotype on fiber density 
at 13 months, at the p<0.01 level for the three conditions [F(2,10)= 10.02, p=0.004] (figure 
7D). Post-hoc comparisons using the Tukey HSD test indicated that the mean score for the 
homozygous KO condition) (M=0.34, SEM=0.02) was significantly different from the 
wildtype (M=0.61, SEM=0.04) condition (p<0.01). The heterozygous (M=0.44, SEM=0.05) 
condition, however, showed no significant differences with either the wildtype or 
homozygous KO groups. Taken together, these results suggest that the complete removal of 
lynx1 is detrimental to axon fiber retention during aging. Partial loss of lynx1, however, is 
apparently sufficient to support neuronal health, even after prolonged periods of reduction 
(figure 7D).
In order to compare the loss of neuronal cell bodies within the striatum in the 13 month old 
wildtype, heterozygous lynx1KO, and lynx1KO mice, we performed immunocytochemical 
analysis of the dorsal striatum using anti-NeuN to label neuronal cell bodies (figure 8). We 
quantified the NeuN positive cells in wildtype (figure 8A) vs. heterozygous lynx1KO (figure 
8B) and lynx1KO (figure 8C) brain sections of the striatal neuropil. There was a significant 
effect of genotype on neuronal cell body number at 13 months, at the p<0.05 level for the 
three conditions [F(2,21)= 19.8, p<0.0001] (figure 8D). Post-hoc comparisons using the 
Tukey HSD test indicated that the mean score for the homozygous KO condition (M=960, 
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SD 85.8) was significantly different from the wildtype (M=1194, SD 93.9) and the 
heterozygous (M=1171, SD 63.2) conditions. There were no significant differences, 
however, between the wildtype vs. heterozygous groups. Taken together, these results 
suggest the complete removal of the lynx1 is detrimental to striatal neuronal health. This 
observation could explain why, in the dorsal striatum of wildtype mice and heterozygous 
mice, axon bundles run in compact fascicles, which show distinct boundaries, but in aged 
lynx1KO mice the boundaries of fascicles become indistinct.
Striatal degeneration as a trigger for vacuole formation
The external degeneration observed in 13 month old animals might have triggered the loss 
of axon bundles, producing the vacuoles observed in the previous study (Miwa et al., 2006). 
We suggest here that fascicles may have been lost when the samples in the previous study 
were switched suddenly from high to low osmolarity in the solution. This change in 
osmolarity could be associated with a transient phase of ‘curling’ in the previous study 
during the staining procedure. In summary, we observed two major differences in the aged 
lynx1KO brain. One is the degeneration of the striatal neuropil, while the other is the 
degeneration within axons of fascicular fibers coursing through the striatum. The most 
extreme ultrastructural change manifested itself at 13 months of age, while 1 and 3 month 
old lynx1KO mice exhibited little to no difference in neuronal structures. The similarity 
between wildtype and heterozygous samples suggests that lynx1 is protective to neurons, 
even at half dosage of the protein.
Discussion
We characterized the dorsal striatum morphologically and found changes in the cellular 
ultrastructure of the lynx1KO mouse brain compared to wildtype mouse brains during aging. 
Before one year of age we saw no substantial difference between wildtype and lynx1KO 
mouse brains. In 13 month old lynx1KO animals, however, there was evidence of altered 
morphology of the fascicles and their integrity appeared weakened. In montages of the 
fascicles, the density of fiber packing was reduced in lynx1KO mice, and there was evidence 
of clearing of both nerve fibers and neuronal cell bodies. In this study, we therefore asked 
what would be the consequence of restricting the degree of lynx1 inhibition over the 
cholinergic system, and capitalized on the partial lynx1 dosage within heterozygous 
lynx1KO mice to carry out our investigations. We found that with partial lynx1 reduction it 
is possible to ameliorate the neuronal loss associated with the aging lynx1KO brains.
Types of altered morphology between and within axons
The external degeneration observed in 13 month old animals might have triggered the loss 
of axon bundles, producing the vacuoles observed in the previous study. The fact that this 
was observed only in the lynx1KO mice suggests that the tissue was weakened or cleared 
out by the degeneration. To summarize the idea that the observed morphology of lynx1KO 
degeneration within the striatum could lead to weakened fascicle structure, we represented 
each individual axon by a cotton-tipped swab, and each fascicle by bundles of swabs (figure 
9A & B). The wildtype and heterozygous axons are regular and parallel, represented by 
parallel swabs (figure 9A). In contrast, the lynx1KO axons are skewed (figure 9B), perhaps 
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because the loss of neuronal cell bodies and clearing of dendritic tissues decreases the 
external mechanical constraints that force the packing of the fascicles. Furthermore, we saw 
the altered ultrastructure of axoplasm in the dorsal striatum. This alteration may signify that 
pathology is transported via axoplasmic flow from defects or signals that originate in cell 
bodies located outside the striatum.
Age-related changes in cholinergic signaling
Aging is associated with changes in cholinergic signaling (Terry and Buccafusco, 2003) 
(Albuquerque et al., 2009) and loss of cholinergic neurons (Decker and McGaugh, 1991; 
Schliebs and Arendt, 2011), as well as loss of axons of cholinergic neurons (Geula et al., 
2008). The aging brain may also be harmed by heightened nicotinic acetylcholine receptor 
function, which could generate excessive calcium signaling. As nicotinic receptor 
modulators, lynx1 molecules may be required to balance nicotinic receptor activity in the 
aging brain. We have reported elevated baseline Ca2+ levels and elevated nicotine-evoked 
Ca2+ transients in primary neuronal cultured neurons from lynx1KO mice (Miwa et al., 
2006). This is consistent with the demonstrated ability of nicotinic receptors to flux Ca2+ 
directly (Colquhoun and Patrick, 1997; Yamauchi et al., 2011), or to induce the release of 
Ca2+ from intracellular calcium stores via downstream effectors (Stevens et al., 2003; 
Vijayaraghavan et al., 1992). In addition to displaying elevations in Ca2+ levels, lynx1KO 
neurons are more susceptible to toxic levels of glutamate. Pre-incubating neurons with low 
doses of nicotine fails to protect lynx1KO mouse neurons, whereas this neuroprotective 
process is robust in wildtype neurons (Miwa et al., 2006). This suggests that lynx1 is playing 
a critical role in protecting neurons via nicotinic receptor mediated Ca2+ dynamics. Elevated 
intracellular Ca2+ levels and exaggerated responses of nicotinic acetylcholine receptors in 
the lynx1KO mouse would make neurons more susceptible to insults over time. A definitive 
mechanism of action for the degenerative pathway awaits further investigation.
Genetic, biochemical, and pharmacological studies have demonstrated that nicotinic 
receptors are downstream effectors of lynx1. The striatal degeneration observed at the light 
microscopic level was ameliorated by crossing the lynx1KO mice to the α7 and β2 KO 
mouse lines (Miwa et al., 2006). This indicates that lynx operates through both subtypes, in 
line with evidence that lynx1 can form stable interactions with both subtypes in binding 
studies (Ibanez-Tallon et al., 2002). As further support for pan-specific interactions with 
nicotinic receptors, pharmacological agents blocking both subtypes, when given as a 
cocktail, can block plasticity effects in lynx1KO mice (Morishita et al., 2010). Multiple 
nicotinic receptor subtypes in the striatum have been reported in rodents (Hill et al., 1993; 
Perez et al., 2008; Zhang et al., 1998), primates (McCallum et al., 2006) and humans (Court 
and Clementi, 1995). α7 (O'Neill et al., 2002; Toulorge et al., 2011), β2 (Stevens et al., 
2003; Zoli et al., 1999), and other nAChRs (Khwaja et al., 2007) have been implicated in 
neuroprotection (Quik and Kulak, 2002). The requirements for neuroprotection are 
influenced by many factors, including developmental stage, receptor subtype, and dosage 
(Picciotto and Zoli, 2008). Lynx1 appears to be critical for nicotine mediated 
neuroprotection (Miwa et al., 2006), and thus lynx1 adds another layer of complexity to our 
understanding of nicotinic receptors and neuroprotection.
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The lynx1KO degeneration occurs at therapeutically relevant sites in the brain. The dorsal 
striatum and the neurons which course through it are important targets for the 
neuroprotective effects of nicotine. Striatal dopamine has been shown to be sensitive to 
nicotine neuroprotection (Costa et al., 2001; Dajas et al., 2001). In vitro studies invoke 
changes in intracellular Ca2+ levels (Toulorge et al., 2011). Whereas nerve fibers traversing 
the striatum were significantly affected, hippocampal sections appeared to be normal at all 
time-points (data not shown), suggesting this susceptibility was specific to cell type. Even 
though we have observed marked regional differences in the degeneration in aged lynx1KO 
mice, these differences do not correlate with areas with the highest levels of lynx1 
expression. Lynx1 mRNA levels are highest in select brainstem nuclei, CA3 of the 
hippocampus, and deep cerebellar nuclear neurons, with moderate levels of expression 
throughout the entire brain (Miwa et al., 1999). The greatest levels of degeneration seen at 
the light microscopic level are observed in the dorsal striatum, cerebellar peduncles, 
brainstem and to a lesser extent, the corpus callosum (Miwa et al., 2006). The selective 
degeneration in the striatum may reflect a selective vulnerability of these neurons to non 
cell-autonomous stressors caused by the absence of lynx1.
Evidence is emerging that lynx1 levels can change due to physiologically relevant events 
and different environmental and network factors (Miwa et al., 2011; Miwa et al., 2012; 
Pfeffer et al.; Sekhon et al, 2005). The sparing of neurons in heterozygous mice reveals that 
partial reductions in lynx levels may be well tolerated in the brain. This may provide a 
demonstration of haplosufficiency of the lynx1 gene with respect to neuronal protection. If 
this extends to learning and cognitive functions, then the lynx1 gene in the brain may be 
involved in a trade-off between neuroprotection and augmented learning. If expression 
levels are altered in specific environmental conditions to optimize this trade-off, the degree 
of cholinergic tone would be able to change in response to situational or environmental 
demands.
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Figure 1. 
Electron micrographs of fascicles in the dorsal striatum of 1 month old and 3 month old-
mice in cross section. In young striatal bundles, the nerve fibers (marked as N) are closely 
packed for both wildtype and lynx1KO mouse, so that the boundary of an individual bundle 
is clearly demarcated (indicated with a dashed line). These schematic images are shown in 
Figure 9A. (1A) Ultrastructural montage of a nerve fiber bundle of a 1 month old wildtype 
mouse. (1B) Ultrastructural montage of a nerve fiber bundle of a 1 month old lynx1KO 
mouse. (1C) Ultrastructural montage of a nerve fiber bundle of a 3 month old wildtype 
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mouse. (1D) Ultrastructural montage of a nerve fiber bundle of a 3 month old lynx1KO. All 
scale bars = 5 µm.
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Figure 2. 
Electron micrograph of a nerve fiber bundle in dorsal striatum of 7- and 13-month-oldmice 
in cross section, for both wildtype and lynx1KO. In 13-month-old striatal bundles from 
wild-type animals, the nerve fibers (N) are still tightly packed, as drawn with dashed lines. 
However, the nerve fibers from the 7-month-old lynx1KO mice appear slightly dispersed 
and the 13-month-old lynx1KO fibers appear to be highly dispersed. a Ultrastructural 
montage of a nerve fiber bundle of a 7-month-old wild type. b Ultrastructural montage of a 
nerve fiber bundle from a 7-month-old lynx1KO mouse. c Ultrastructural montage of a 
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nerve fiber bundle from a 13-month-old wild type animal. d Ultrastructural montage of a 
nerve fiber bundle from a 13-month-old lynx1KO. Although some of the bundles (lower left 
fascicle) appear to be packed, many (upper right) have lost their shape so that the boundary 
cannot be easily demarcated (shown by the "?” marks). All scale bars 5 µm. e Bar graph of 
nerve fiber density in a fascicle (# of nerve fibers per µm2). [F(3,11)=6.11, p<0.01] by 
ANOVA. Post-hoc Tukey test indicates a significant difference in the mean when comparing 
the 13-month-old lynx1KO fiberdensity (56.4±9.3%, n=3) to that in 13-month-old wild-type 
(100.0 ± 5.8%, n=5). Densities in young wild-type (88.2 ±11.0%, n=4) and young lynx1KO 
samples (77.1 ± 4.2%, n=3) were not significantly different. y-axis is in %, data normalized 
to the 13-month-old wild-type nerve fiber density.
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Figure 3. 
Nerve fibers in the fascicles are markedly disrupted in lynx1KO mice. High power 
micrographs of the 13 month old lynx1KO striatal fascicles reveals marked disruption in the 
region between individual nerve fibers. In some cases, the diameters of the axons 
themselves, or the myelin sheaths surrounding them, appeared shrunken. In some cases the 
myelin appear to be degenerated (marked as SD), and the interior of the axon appears 
vacuolated (marked as NV). (3A) 13 month old wildtype mouse brain. (3B) 13 month old 
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wildtype mouse brain, higher power. (3C) 13 month old lynx1KO mouse brain. (3D) 13 
month old lynx1KO mouse brain, higher power. All scale bars are 1um.
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Figure 4. 
Microscopic examination of 13 month old striatal neuropil. (4A) Electron micrograph of 
wildtype mouse. Part of an individual nerve fiber (marked as N) is shown at bottom. (4B) 
Electron micrograph of wildtype mouse at higher magnification. For wildtype animals, the 
nerve fiber bundles are still packed by parts of dendritic (marked as DR) and neuronal cell 
bodies. (4C) Electron micrograph of lynx1KO mouse. (4D) Electron micrograph of 
lynx1KO mouse at higher magnification. The tissues in the lynx1KO mouse contain many 
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areas that lack intracellular structures as compared to the wildtype mice. Areas between the 
dendrites appear empty (marked as E). All scale bars = 1µm.
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Figure 5. 
Electron micrograph of the somatic structures in the striatal neuropil between fascicles show 
disruption of nuclei evident in aging lynx1KO brains. Lynx1KO samples appear to contain 
condensed and clear nuclei, and empty spaces between nerve structures in the striatum. (5A) 
13 month old wildtype striatum. (5B) 13 month old lynx1KO striatum. Cell nuclei appear 
condensed or cleared. All scale bars are 1um.
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Figure 6. 
Measurements of lynx1 levels using qPCR and Western analyses. (6A) qPCR analysis 
indicates 50% of the transcript levels in heterozygous lynx1KO mice as compared to those 
of wildtype mice. y-axis is fold level of expression of lynx1 relative to wildtype levels. (6B) 
Western blot of total brain protein extracts from 13 month old mice, run out in triplicate and 
detected with anti-lynx1 antibodies. (6C) Quantitation of lynx1 bands indicates protein 
levels in the heterozygous mice that are ~50% of wildtype levels, and is absent in 
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homozygous lynx1KO extracts. y-axis is fold level of lynx protein relative to wildtype 
levels.
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Figure 7. 
Microscopic examination of 13 month old heterozygous lynx1KO mice reveals that titrating 
lynx1 dosage protects neurons. (7A) The nerve fibers (marked as N) are closely packed in 
heterozygous lynx1KO mice, so that the boundary of an individual bundle is clearly 
demarcated (indicated with a dashed line). These schematic images are shown in Figure 9A. 
(7B) Part of an individual nerve fiber (marked as N) is shown. (7C) Electron micrograph of 
the somatic structures in the striatal neuropil between fascicles shows that the nerve fibers 
(marked as N) are still packed by the parts of dendritic structures (marked as DR). (7D) Bar 
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graph of axon fiber density. y-axis is number of axons in a fascicle/area in µm2. Wildtype is 
0.61 ± 0.04, n=4, heterozygous lynx1KO 13 month old is 0.44 ± 0.05, n=5, and lynx1KO is 
0.34 ± 0.02, n=3. F(2,9)= 6.57, p < 0.01)].
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Figure 8. 
Neurons are lost in aging dorsal striatum of lynx1KO mice, but titrating lynx dosage protects 
neurons. All images taken at 63x magnification. (8A) 13 month old wildtype mouse brain 
stained with neuronal marker NeuN. (8B) 13 month old heterozygous lynx1KO mouse brain 
stained with NeuN. (8C) 13 month old lynx1KO mouse brain stained with NeuN. (8D) Box 
plot of number of neurons as assessed by NeuN positive staining. y-axis plots number of 
NeuN positive neurons per region.
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Figure 9. 
Schematic models of axon bundle fascicles of (9A) 13 month old wildtype and heterozygous 
lynx1KO mice, and (9B) the dispersed bundles of 13 month old homozygous lynx1KO, 
illustrated by the clumping of cotton-tipped swabs which represent myelinated axon fibers.
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